BR0314823A - Andaime programável e métodos para o preparo e uso do mesmo - Google Patents

Andaime programável e métodos para o preparo e uso do mesmo

Info

Publication number
BR0314823A
BR0314823A BR0314823-8A BR0314823A BR0314823A BR 0314823 A BR0314823 A BR 0314823A BR 0314823 A BR0314823 A BR 0314823A BR 0314823 A BR0314823 A BR 0314823A
Authority
BR
Brazil
Prior art keywords
scaffolding
programmable
preparing
methods
biologically active
Prior art date
Application number
BR0314823-8A
Other languages
English (en)
Inventor
John Rowley
Mohammad Heidaran
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of BR0314823A publication Critical patent/BR0314823A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
    • C12M25/14—Scaffolds; Matrices
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/30—Synthetic polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C12N2533/54—Collagen; Gelatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/72—Chitin, chitosan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Sustainable Development (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)

Abstract

"ANDAIME PROGRAMáVEL E MéTODOS PARA O PREPARO E USO DO MESMO". A presente invenção se refere a um andaime programável, o qual pe um andaime tridimensional tendo poros interconectados e moléculas biologicamente ativas fIsicamente apanhadas neste. o andaime é um hidrogel liofilizado de um polímero. o andaime pode ser empregado em uma disposição em uma plataforma e carregado com várias combinações de moléculas biologicamente ativas para produção elevada e avaliação paralela, bem como construção de tecido. A presente invenção também se refere a método para a preparação e modificação dos andaimes.
BR0314823-8A 2002-09-30 2003-09-30 Andaime programável e métodos para o preparo e uso do mesmo BR0314823A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/259,817 US20040063206A1 (en) 2002-09-30 2002-09-30 Programmable scaffold and method for making and using the same
PCT/US2003/030649 WO2004031371A2 (en) 2002-09-30 2003-09-30 Programmable scaffold and methods for making and using the same

Publications (1)

Publication Number Publication Date
BR0314823A true BR0314823A (pt) 2005-08-02

Family

ID=32029560

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0314823-8A BR0314823A (pt) 2002-09-30 2003-09-30 Andaime programável e métodos para o preparo e uso do mesmo

Country Status (9)

Country Link
US (1) US20040063206A1 (pt)
EP (1) EP1565551A2 (pt)
JP (1) JP2006500953A (pt)
KR (1) KR20050071520A (pt)
CN (1) CN1694955A (pt)
AU (1) AU2003277040A1 (pt)
BR (1) BR0314823A (pt)
CA (1) CA2500410A1 (pt)
WO (1) WO2004031371A2 (pt)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790192B2 (en) 1998-08-14 2010-09-07 Accessclosure, Inc. Apparatus and methods for sealing a vascular puncture
US20040147016A1 (en) * 2002-09-30 2004-07-29 Rowley Jonathan A. Programmable scaffold and methods for making and using the same
US8138265B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US7465766B2 (en) * 2004-01-08 2008-12-16 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US6982298B2 (en) * 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
US8137688B2 (en) * 2003-01-10 2012-03-20 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
EP1633807B8 (de) * 2003-06-06 2017-03-15 Human Auto Cell Limited Matrix, zellimplantat, verfahren zu deren herstellung und deren verwendung
US20050095711A1 (en) * 2003-11-01 2005-05-05 More Robert B. Bioreactor for growing engineered tissue
DE102004039762A1 (de) * 2004-08-17 2006-03-02 Wilden Ag Substrat, Verfahren zu seiner Herstellung und Verwendung für die Bildung von Kulturen aus organischen Zellen
JP2006087396A (ja) * 2004-09-27 2006-04-06 National Institute For Environmental Studies 細胞培養基質及びその製造方法
DE102004059169A1 (de) * 2004-12-08 2006-06-22 Humanautocell Gmbh Verfahren zum Testen von Substanzen an Biomatrices
WO2006101453A1 (en) * 2005-03-22 2006-09-28 Agency For Science, Technology And Research Scaffold and method of forming scaffold by entangling fibres
EP1931764A1 (en) * 2005-06-21 2008-06-18 GE Healthcare Bio-Sciences AB Method for cell culture
AU2014200405B2 (en) * 2005-12-13 2015-09-03 President And Fellows Of Harvard College Scaffolds for cell transplantation
US8067237B2 (en) * 2005-12-13 2011-11-29 President And Fellows Of Harvard College Scaffolds for cell transplantation
KR100715505B1 (ko) 2006-01-07 2007-05-08 민병현 세포 유래 세포외 기질 지지체의 제조방법
CN102586106B (zh) * 2006-01-23 2014-02-05 杨炜 三维空间细胞培养系统制备方法
US8795709B2 (en) * 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
BRPI0808696A2 (pt) * 2007-03-06 2015-06-23 Univ North Carolina Complexos de hiluronanas, outros componentes de matriz, hormônios e fatores de crescimento para manutenção, expansão e/ou diferenciação de células
AU2008223798A1 (en) * 2007-03-07 2008-09-12 Coloplast A/S Mesh comprising ECM
JP2010520766A (ja) 2007-03-09 2010-06-17 コーニング インコーポレイテッド 細胞培養用三次元ガムマトリックス、製造方法および使用方法
US20100136645A1 (en) * 2007-04-17 2010-06-03 Byoung-Hyun Min Method for preparing a cell-derived extracellular matrix scaffold
US9770535B2 (en) * 2007-06-21 2017-09-26 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
EP2200671B1 (en) 2007-10-11 2013-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for preparing porous scaffold for tissue engineering
EP2209426A4 (en) 2007-11-02 2015-04-22 Incept Llc APPARATUS AND METHODS FOR CLOSING VASCULAR PERFORATION
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
US8080260B2 (en) 2008-02-13 2011-12-20 The Cleveland Clinic Foundation Molecular enhancement of extracellular matrix and methods of use
WO2009102465A2 (en) 2008-02-13 2009-08-20 President And Fellows Of Harvard College Continuous cell programming devices
WO2009135029A2 (en) * 2008-04-30 2009-11-05 The Cleveland Clinic Foundation Compositions and methods to treat urinary incontinence
US9012399B2 (en) * 2008-05-30 2015-04-21 President And Fellows Of Harvard College Controlled release of growth factors and signaling molecules for promoting angiogenesis
US20110110888A1 (en) * 2008-06-27 2011-05-12 Hai-Qing Xian Scaffold Coated and/or Impregnated with at Least One Bioactive Agent for Tissue Repair and Other Medical Applications
US10842645B2 (en) 2008-08-13 2020-11-24 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
US9616205B2 (en) 2008-08-13 2017-04-11 Smed-Ta/Td, Llc Drug delivery implants
US9700431B2 (en) 2008-08-13 2017-07-11 Smed-Ta/Td, Llc Orthopaedic implant with porous structural member
ES2647919T3 (es) 2008-08-13 2017-12-27 Smed-Ta/Td, Llc Implantes de suministro de fármaco
US20100042213A1 (en) 2008-08-13 2010-02-18 Nebosky Paul S Drug delivery implants
WO2010025386A1 (en) 2008-08-29 2010-03-04 Smed-Ta/Td, Llc Orthopaedic implant
US20110293722A1 (en) 2008-12-04 2011-12-01 Techion Research And Development Foundation Ltd. Hydrogel sponges, methods of producing them and uses thereof
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
WO2010120749A2 (en) 2009-04-13 2010-10-21 President And Fellow Of Harvard College Harnessing cell dynamics to engineer materials
AU2010246115A1 (en) 2009-05-04 2011-12-08 Incept. Llc Biomaterials for track and puncture closure
CA2768552A1 (en) 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
KR101106022B1 (ko) * 2009-10-28 2012-01-17 공주대학교 산학협력단 세포 기반 주화성 키트 및 이의 제조 방법
KR101637431B1 (ko) 2010-03-02 2016-07-07 후지필름 가부시키가이샤 세포 지지체 및 골재생재
EP2542230A4 (en) 2010-03-05 2013-08-28 Harvard College ENHANCEMENT OF SKELETAL MUSCLE STRAIN CELL GRAFT WITH DUAL DELIVERY OF VEGF AND IGF-1
US9693954B2 (en) 2010-06-25 2017-07-04 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
AU2011289214B2 (en) 2010-08-13 2015-05-28 Wake Forest University Health Sciences Methods for making a tissue engineered muscle repair (TEMR) construct in vitro for implantation in vivo
AU2011311904B2 (en) 2010-10-06 2016-02-25 President And Fellows Of Harvard College Injectable, pore-forming hydrogels for materials-based cell therapies
KR101303695B1 (ko) * 2010-10-18 2013-09-09 대한민국 저분자 실크 피브로인과 아가로스 겔을 이용한 3차원 지지체 및 그 제조방법
KR101219646B1 (ko) * 2010-10-19 2013-01-11 대한민국 아가로스를 이용한 다공성 3차원 지지체의 제조방법 및 이를 통해 제조된 다공성 3차원 지지체
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
ES2870965T3 (es) 2011-01-19 2021-10-28 Access Closure Inc Procedimientos para sellar una punción vascular
US9820728B2 (en) 2011-01-19 2017-11-21 Access Closure, Inc. Apparatus and methods for sealing a vascular puncture
EP2701753B1 (en) 2011-04-27 2018-12-26 President and Fellows of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
ES2878089T3 (es) 2011-04-28 2021-11-18 Harvard College Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
EP2714073B1 (en) 2011-06-03 2021-03-10 President and Fellows of Harvard College In situ antigen-generating cancer vaccine
CN102266588B (zh) * 2011-07-28 2013-07-10 西安交通大学 一种基于蔗糖纤维模板的载细胞微通道水凝胶的制备方法
CN102266589B (zh) * 2011-07-28 2013-10-16 西安交通大学 一种力学增强型载细胞微通道水凝胶的制备方法
JP5808631B2 (ja) * 2011-09-29 2015-11-10 富士フイルム株式会社 血管新生用足場、及び再生医療用の血管の製造方法
CA2849987C (en) * 2011-09-30 2023-03-14 Wake Forest University Health Sciences Bioscaffolds for formation of motor endplates and other specialized tissue structures
EP2804586A4 (en) * 2012-01-19 2016-03-16 Univ Johns Hopkins BIOMATERIALS COMPRISING HYALURONIC ACID-BINDING PEPTIDES AND BIFUNCTIONAL BIOPOLYMER MOLECULES FOR HYALURONIC ACID RETENTION AND TISSUE ENGINEERING APPLICATIONS
DK2838515T3 (da) 2012-04-16 2020-02-24 Harvard College Mesoporøse siliciumdioxidsammensætninger til modulering af immunresponser
US20140072510A1 (en) * 2012-09-13 2014-03-13 Northwestern University Synthetic Scaffolds for Metastasis Detection
TWI601817B (zh) 2013-10-02 2017-10-11 國立中央大學 細胞培養製品及其製造方法
CN103751858B (zh) * 2014-01-07 2015-03-04 东南大学 能促进血管再生的可吸收骨科器械材料及其制备方法
CN103768661B (zh) * 2014-01-07 2015-03-04 东南大学 能缓释硒元素的可吸收骨科器械材料及其制备方法
US10682400B2 (en) 2014-04-30 2020-06-16 President And Fellows Of Harvard College Combination vaccine devices and methods of killing cancer cells
CN104307046B (zh) * 2014-10-27 2016-06-08 南京医科大学附属南京医院 一种可注射骨髓间充质干细胞外基质/琼脂糖复合水凝胶及其制备方法和应用
CN104399118B (zh) * 2014-12-10 2017-11-17 武汉理工大学 一种神经生长因子可注射原位水凝胶、制备及其应用
ES2577883B2 (es) * 2014-12-16 2016-11-21 Universitat Politècnica De València Biohíbrido para su uso en la regeneración de tractos neurales
EP3250250A4 (en) 2015-01-30 2019-05-22 President and Fellows of Harvard College PERITUMORAL AND INTRATUMORAL MATERIALS FOR CANCER THERAPY
WO2016138274A1 (en) * 2015-02-25 2016-09-01 3-D Matrix, Ltd. Synthetic peptide hydrogel formulations for use as extracellular matrix
JP7094533B2 (ja) 2015-04-10 2022-07-04 プレジデント アンド フェローズ オブ ハーバード カレッジ 免疫細胞捕捉デバイスおよびその製造および使用方法
CN115531609A (zh) 2016-02-06 2022-12-30 哈佛学院校长同事会 重塑造血巢以重建免疫
BR112018073575B1 (pt) * 2016-05-17 2021-12-21 Leibniz-Institut für Polymerforschung Dresden e. V. Processo para formação de uma rede funcional de células neurais e gliais humanas, rede funcional tridimensional, neural, humana, e aplicação do processo
EP3484448A4 (en) 2016-07-13 2020-04-01 President and Fellows of Harvard College MIMETIC SCAFFOLDS OF CELLS HAVING ANTIGEN AND METHODS OF PREPARING AND USING THEM
WO2018073235A1 (en) * 2016-10-18 2018-04-26 Aarhus Universitet Printed hyaluronic acid scaffolds
CN108578617B (zh) * 2018-04-09 2021-03-30 深圳市莱利赛生物科技有限公司 促进膝关节软骨再生用脐血间质干细胞药物的制备方法
IT201800020242A1 (it) * 2018-12-19 2020-06-19 Milano Politecnico Substrato tridimensionale per le colture microbiche
CN111518755A (zh) * 2020-05-09 2020-08-11 苏州大学 一种仿生骨膜、骨膜-骨替代物及制备方法
CN112778544B (zh) * 2021-01-21 2021-12-03 江南大学 用于肌肉干细胞培养的交联水凝胶及其制备方法和应用
CN113430159B (zh) * 2021-05-19 2022-04-12 广东乾晖生物科技有限公司 仿生细胞外基质生物活性物质覆层聚酯网状片层支架
CN113318270B (zh) * 2021-05-19 2022-03-08 南方医科大学珠江医院 生物活性物质覆层聚酯网状片层支架的制备方法
WO2022265585A1 (en) * 2021-06-18 2022-12-22 Chulalongkorn University Method of fabricating an implantable construct and an implantable construct derived from the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205790B1 (de) * 1985-06-18 1992-01-08 Anawa München Aktiengesellschaft Biologische Laboratorien Träger für die Kultivierung von menschlichen und/oder tierischen Zellen in einem Fermenter
GB2281861B (en) * 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US5747027A (en) * 1995-04-07 1998-05-05 The Regents Of The University Of California BH55 hyaluronidase
DE69631490T2 (de) * 1995-11-09 2004-10-07 Univ Massachusetts Boston Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen
IL118376A0 (en) * 1996-05-22 1996-09-12 Univ Ben Gurion Polysaccharide sponges for cell culture and transplantation
US5866165A (en) * 1997-01-15 1999-02-02 Orquest, Inc. Collagen-polysaccharide matrix for bone and cartilage repair
ATE227338T1 (de) * 1998-03-18 2002-11-15 Massachusetts Inst Technology Vaskularisierte perfundierte anordnungen für mikrogewebe und mikroorgane
US6103528A (en) * 1998-04-17 2000-08-15 Battelle Memorial Institute Reversible gelling culture media for in-vitro cell culture in three-dimensional matrices
US6511650B1 (en) * 1999-04-09 2003-01-28 The Regents Of The University Of Michigan Preparing porous hydrogel products
WO2001049824A2 (en) * 2000-01-05 2001-07-12 Novartis Ag Cell growth substrate hydrogels
US20030095993A1 (en) * 2000-01-28 2003-05-22 Hanne Bentz Gel-infused sponges for tissue repair and augmentation
WO2001066695A1 (en) * 2000-03-06 2001-09-13 United States Surgical Corporation Tissue compositions using cultured fibroblasts and keratinocytes and methods of use thereof
AU2002365110A1 (en) * 2001-07-10 2003-07-15 Massachusetts Institute Of Technology Small molecule microarrays

Also Published As

Publication number Publication date
EP1565551A2 (en) 2005-08-24
AU2003277040A1 (en) 2004-04-23
US20040063206A1 (en) 2004-04-01
WO2004031371A2 (en) 2004-04-15
CA2500410A1 (en) 2004-04-15
JP2006500953A (ja) 2006-01-12
CN1694955A (zh) 2005-11-09
KR20050071520A (ko) 2005-07-07
WO2004031371A3 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
BR0314823A (pt) Andaime programável e métodos para o preparo e uso do mesmo
WO2005035735A3 (en) Programmable scaffold, and methods for making and using the same
DE602006018721D1 (de) Cyanidfreie lösungsmittelzusammensetzung und verwendungsverfahren dafür zur messung von hämoglobin und weissen blutkörperchen
DE60208869D1 (de) Poröse Gerüstmatrix zur Reparatur und Regeneraton von dermalem Gewebe
WO2004062697A3 (en) Silk fibroin materials and use thereof
WO2009120513A3 (en) Malleable multi-component implants and materials therefor
BRPI0509946B8 (pt) composição na forma de micropartículas para a liberação prolongada de um polipeptídeo biologicamente ativo
DE50015883D1 (de) Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie
DE60238416D1 (de) Plasmaprotein-matritzes und verfahren zu ihrer herstellung
PT84188B (pt) Processo de preparacao de uma composicao farmaceutica para a obtencao de um hidrogel ou de uma suspensao, muito viscosos
ATE395924T1 (de) Wiederherstellung zerstörten gewebes mit hilfe von multipotenten zellen
ES2534304T3 (es) Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
DE602004029236D1 (de) Cyclische harnstoffderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung als kinaseinhibitoren
NZ591338A (en) Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
ATE409050T1 (de) Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten
DE602004015570D1 (de) Makromolekulare ketoaldehyden und verfahren zu dessen herstellung
WO2003094617A3 (en) Use of vegf for treating bone defects
DE602007005244D1 (de) N-carbamoylmethyl-4-(r)-phenyl-2-pyrrolidinon, verfahren zu dessen herstellung und pharmazeutische verwendung
DK1067911T3 (da) Hydrogelsammensætninger, der kan anvendes til opretholdt frigivelse af makromolekyler, samt fremgansmåder tilfremstilling deraf
ATE512784T1 (de) Reckstange und eine vorrichtung und ein verfahren zur herstellung von hohlkörpern mittels der reckstange
DE602006016285D1 (de) Derivate von 4,5-diarylpyrrol, verfahren zu deren herstellung und deren verwendung in therapeutika
DE60315203D1 (de) Kationische amphiphile Assoziativpolymere, Verfahren zur Herstellung, Verwendung als Verdickungsmittel und Zusammensetzung
ATE466558T1 (de) Scharniergelenk für eine knieschiene mit einem mittel zu seiner bedienung
ATE472730T1 (de) Verfahren zum testen von substanzen an biomatrices
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 5A., 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2069 DE 31/08/2010.

B15K Others concerning applications: alteration of classification

Ipc: C12N 5/00 (2006.01), A61L 27/38 (2006.01), A61L 27